Annals of Family Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Annals of Family Medicine 7:32-40 (2009)
© 2009 Annals of Family Medicine, Inc.
doi: 10.1370/afm.910

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow In Brief
Right arrow TRACK Discussion: Submit a Comment
Right arrow TRACK Discussion: View Comments
Right arrow Alert me when this article is cited
Right arrow Alert me when TRACK Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zuidgeest, M. G. P.
Right arrow Articles by Leufkens, H. G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zuidgeest, M. G. P.
Right arrow Articles by Leufkens, H. G. M.
Related Collections
Right arrow Chronic illness
Right arrow Children's health
Right arrow Community / population health
Right arrow Quantitative methods
Right arrow Professional practice

What Drives Prescribing of Asthma Medication to Children? A Multilevel Population-Based Study

Mira G. P. Zuidgeest, PharmD, PhD1,3, Liset van Dijk, PhD2, Peter Spreeuwenberg, MA2, Henriëtte A. Smit, MD, PhD3, Bert Brunekreef, PhD4,5, Hubertus G. M. Arets, MD, PhD6, Madelon Bracke, PhD1 and Hubert G. M. Leufkens, PharmD, PhD1

1 Division of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands
2 NIVEL (Netherlands Institute for Health Services Research), Utrecht, The Netherlands
3 Centre of Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
4 Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
5 Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands
6 Department of Paediatric Pulmonology, Wilhelmina Children’s Hospital, University Medical Centre, Utrecht, The Netherlands

CORRESPONDING AUTHOR: Bert Leufkens, PhD, Division of Pharmacoepidemiology & Pharmacotherapy, Utrecht University, PO Box 80082, 3508 TB, Utrecht, The Netherlands, h.g.m.leufkens{at}uu.nl

PURPOSE Diagnosing asthma in children with asthmatic symptoms remains a challenge, particularly in preschool children. This challenge creates an opportunity for variability in prescribing. The aim of our study was to investigate how and to what degree patient, family, and physician characteristics influence prescribing of asthma medication in children.

METHODS We undertook a multilevel population-based study using the second Dutch national survey of general practice (DNSGP-2), 2001. Participants were 46,371 children aged 1 to 17 years belonging to 25,537 families registered with 109 general practitioners. Using a multilevel multivariate logistic regression analysis with 3 levels, our main outcome measure was the prescribing of asthma medication, defined as at least 1 prescription for β2-adrenergic agonists, inhaled corticosteroids, cromones, or montelukast during the 1-year study period.

RESULTS We identified characteristics significantly associated with prescribing asthma medication on all 3 levels (child, family, and physician). The variance in prescribing among physicians was significantly higher with children who were younger than 6 years than with children aged 6 years and older (95% CI, 3.5%–25.2% vs 2.4%–13.4%). Several diagnoses other than asthma and asthmatic complaints were strongly associated with prescribing asthma medication, including bronchitis/bronchiolitis (OR = 9.04; 95% CI, 7.57–10.8) and cough (OR = 6.51; 95% CI, 5.68–7.47).

CONCLUSIONS Our study shows a much higher variance in prescribing patterns among general practitioners for children younger than 6 years compared with older children, which could be a direct result of the diagnostic complexities found in young children with asthmatic symptoms. Thus diagnostic gaps may lead to more physician-driven prescribing irrespective of the clinical context.

Key Words: Asthma/child • asthma/child, preschool • family practice • professional practice • multilevel • pharmacoepidemiology • prescribing




This article has been cited by other articles:


Home page
Ann Fam MedHome page
R. S. Gotler and K. C. Stange
A Way Forward for Health Care and Healers
Ann. Fam. Med, May 1, 2009; 7(3): 273 - 274.
[Full Text] [PDF]


Home page
Ann Fam MedHome page
K. C. Stange
Implementation Insights
Ann. Fam. Med, March 1, 2009; 7(2): 179 - 181.
[Full Text] [PDF]


Home page
Ann Fam MedHome page
K. C. Stange
The Complexity of and Opportunity for Screening in Primary Care
Ann. Fam. Med, January 1, 2009; 7(1): 2 - 3.
[Full Text] [PDF]

TRACK Comments:

Read all TRACK Comments

How to explain these findings?
Johannes C van der Wouden, et al.
Annals of Family Medicine, 29 Jan 2009 [Full text]
Overtreating Asthma in Preschool Children: Is it a Public Health Problem?
Herberto J Chong Neto, et al.
Annals of Family Medicine, 16 Mar 2009 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Annals of Family Medicine.